Laura E Niklason is President, CEO and Director of Humacyte, Inc.. Currently has a direct ownership of 242,054 shares of HUMA, which is worth approximately $1.07 Million. The most recent transaction as insider was on Aug 29, 2024, when has been sold 1,222 shares (Common Stock) at a price of $6.54 per share, resulting in proceeds of $7,991. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 242K
0.51% 3M change
82.52% 12M change
Total Value Held $1.07 Million

Laura E Niklason Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 29 2024
BUY
Open market or private purchase
$7,991 $6.54 p/Share
1,222 Added 0.5%
242,054 Common Stock
Jun 04 2024
BUY
Open market or private purchase
$14,998 $6.35 p/Share
2,362 Added 0.97%
240,832 Common Stock
Jun 03 2024
BUY
Open market or private purchase
$15,108 $7.37 p/Share
2,050 Added 0.85%
238,470 Common Stock
Oct 10 2023
BUY
Exercise of conversion of derivative security
$136,159 $1.19 p/Share
114,420 Added 7.63%
1,384,660 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
$119,000 $1.19 p/Share
100,000 Added 7.3%
1,270,240 Common Stock
Dec 15 2022
BUY
Open market or private purchase
$25,400 $2.54 p/Share
10,000 Added 0.85%
1,170,240 Common Stock
Sep 15 2022
BUY
Open market or private purchase
$8,280 $4.14 p/Share
2,000 Added 0.17%
1,160,240 Common Stock
May 23 2022
BUY
Open market or private purchase
$48,300 $4.83 p/Share
10,000 Added 0.86%
1,158,240 Common Stock
Aug 26 2021
BUY
Grant, award, or other acquisition
-
1,148,240 Added 50.0%
1,148,240 Common Stock
LEN

Laura E Niklason

President, CEO and Director
Durham, NC

Track Institutional and Insider Activities on HUMA

Follow Humacyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HUMA shares.

Notify only if

Insider Trading

Get notified when an Humacyte, Inc. insider buys or sells HUMA shares.

Notify only if

News

Receive news related to Humacyte, Inc.

Track Activities on HUMA